SEC 13F Intelligence

Elevate Capital Advisors, LLC / LLY

Elevate Capital Advisors, LLC’s Eli Lilly & Co Position

Does Elevate Capital Advisors, LLC own Eli Lilly & Co (LLY)? Yes — 2.7K shares worth $3M (+1.62% of its 13F portfolio) as of Q1 2026, up from 2.4K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
2.7K
% of Portfolio
+1.62%
Quarters Held
6
currently held

Position History LLY

Reported value by quarter
Q4 ’24: $262,099Q4 ’24Q1 ’25: $270,992Q1 ’25Q2 ’25: $300,246Q2 ’25Q3 ’25: $496,604Q3 ’25Q4 ’25: $3MQ4 ’25Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.7K$3M+1.62%
Q4 20252.4K$3M+1.73%
Q3 2025651$496,604+0.35%
Q2 2025385$300,246+0.24%
Q1 2025328$270,992+0.25%
Q4 2024340$262,099+0.23%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Elevate Capital Advisors, LLC’s full portfolio or all institutional holders of LLY.